US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Quasi-New Stocks

693.03

+4.110.60%

Number of Gainers:71

Number of Losers:69

Number of Flat:14

PE:- -

High:698.21

Open:689.82

Low:685.07

Close:688.92

Volume:272.16M

Turnover:8.90B

Market Cap:479.85B

Float Cap:365.12B

Loading ...

iPower Announces Special Shareholder Meeting

Atai Beckley Holds Shareholder Meeting, Quorum Met with 65.6% Shares Represented

Keros Therapeutics Announces Share Repurchase Authorization Program

Sangamo Therapeutics Completes Key Technology Asset Sale

Robinhood initiated with a Buy at StoneX

Kanzhun Details September 2026 Option Exercises and Share Count Changes

Acurx Pharmaceuticals - Files for Resale of 1,500,000 Common Shares - SEC Filing

THOMSON REUTERS

Riskified Director Shachar Erez Disposes of USD 336,010 Common Shares

Xponential Fitness Appoints Jennifer Ryu as CFO Effective Oct. 19, 2026

Keros Therapeutics announces $5M share repurchase program after Takeda payment

Oklo initiated with an Overweight at Piper Sandler

Xponential Fitness, - Appoints Jennifer Ryu as CFO Effective October 19, 2026

THOMSON REUTERS

Xponential Fitness, - Robert Julian to Step Down as Interim CFO, Remain as Consultant

THOMSON REUTERS

Xponential Fitness, Inc. Appoints Jennifer Ryu as Chief Financial Officer

THOMSON REUTERS

Protara Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference

CAMP4 Therapeutics to Host Virtual Analyst Day to Discuss CMP-002 for the Treatment of SYNGAP1-Related Disorder on September 28, 2026

Press Release: Korsana Biosciences Completes Closing of Merger with Cyclerion Therapeutics and Previously Announced Private Placement of $380 Million

ME Therapeutics Advances Dual-Target CAR and STING mRNA Programs as NASDAQ Plans Progress

Shares of Beam Therapeutics Retreat After Updated Trial Data Disappoints

Waterdrop Shares Rise After Q2 Results, New Buyback Plan

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigreclipse.com/stock/BK4539/news?page=15"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4539","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","market":"US","secType":"PLATE","nameCN":"Quasi-New Stocks","latestPrice":693.02655,"timestamp":1789156799999,"preClose":688.91504,"halted":0,"volume":272157313,"delay":0,"changeRate":0.005968,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":4.111511,"latestTime":"09-11 16:00:00 EDT","open":689.8237,"high":698.2087,"low":685.0665,"amount":8901943117.280722,"amplitude":0.019077,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.322141,"peRate":139.801509,"turnoverRate":0.021443,"increases":71,"decrements":69,"flats":10,"marketCap":479852364396.5,"floatMarketCap":365120021896},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4539\",,,,,undefined,":{"symbol":"BK4539","high":698.2087,"amplitude":0.019077,"preClose":688.91504,"low":685.0665,"pbRate":"5.322141","latestPrice":693.02655,"volume":272157313,"delay":0,"open":689.8237,"prevYearClose":881.5255,"prevWeekClose":725.2816,"prevMonthClose":701.0681,"prevQuarterClose":742.922,"fiveDayClose":733.4782,"twentyDayClose":682.8836,"sixtyDayClose":729.1859,"secType":"PLATE","market":"US","turnoverRate":0.021443,"peRate":139.801509,"marketCap":479852364396.5,"floatMarketCap":365120021896,"timestamp":1789156799999,"nameCN":"Quasi-New Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4539\",,,,undefined,":{"bkCode":"BK4539","up":71,"down":69,"flat":14},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4539\",pageSize:20,pageCount:15,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666370965","title":"iPower Announces Special Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2666370965","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666370965?lang=en_us&edition=fundamental","pubTime":"2026-09-09 05:17","pubTimestamp":1788902252,"startTime":"0","endTime":"0","summary":"iPower announces special shareholder meetingiPower schedules a virtual special stockholder meeting on Sept. 21, 2026.Vote on authorizing up to USD 10 million in common stock issuance, capped at 10,000","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDLbglcjB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4122","BK4539","IPW","BK4104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666370615","title":"Atai Beckley Holds Shareholder Meeting, Quorum Met with 65.6% Shares Represented","url":"https://stock-news.laohu8.com/highlight/detail?id=2666370615","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666370615?lang=en_us&edition=fundamental","pubTime":"2026-09-09 05:10","pubTimestamp":1788901814,"startTime":"0","endTime":"0","summary":"Atai Beckley holds shareholder meeting, quorum met with 65.6% shares representedAtai Beckley held a virtual special shareholder meeting on Sept. 8, 2026 to vote on a merger agreement with Eli Lilly.Sh","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL1JLSHz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2213496289.HKD","FHLC","LU1548497426.USD","LU2237443622.USD","BK4516","LU0210536198.USD","LU1623119135.USD","LU0096364046.USD","SGXZ31699556.SGD","XLV","LU0158827781.USD","LU0820561818.USD","ILDR","IE00B1BXHZ80.USD","LU0823434583.USD","IE00BK4W5L77.USD","BK4539","IE0005OL40V9.USD","LU0943347566.SGD","IXJ","BK4533","GDOC","LU2756315318.SGD","LU2357305700.SGD","LU0316494557.USD","SG9999001176.USD","IE00BJJMRZ35.SGD","LU1868836757.USD","JDOC","LU0106261372.USD","LU2237443895.HKD","LU0354030438.USD","LU2324357040.USD","LU2471134796.USD","LU2063271972.USD","IE00BFTCPJ56.SGD","TMED","LU2552382215.SGD","LU1551013342.USD","LU0385154629.USD","LU0345770308.USD","LU1127390331.HKD","LU0061475181.USD","LU1323610961.USD","LU0203202063.USD","LU2471134879.HKD","LU0114720955.EUR","LU0889565916.HKD","LU1093756168.USD","LU1712237335.SGD","LU2111349929.HKD","IE0004445015.USD","SG9999014906.USD","IE00BJJMRY28.SGD","LU2108987350.USD","LU2265009873.SGD","LU2491050071.SGD","SG9999013999.USD","SGXZ99366536.SGD","CANC","IE00BFSS8Q28.SGD","LU0689472784.USD","LU1720051017.SGD","LU2168564065.EUR","LU2237443382.USD","SG9999014898.SGD","LU2750360997.AUD","LU2023251221.USD","IE00BKPKM429.USD","LU0787776722.HKD","LU1064131342.USD","LU0203201768.USD","LU2087625088.SGD","SG9999017495.SGD","RXL","LU2089284900.SGD","LU0786609619.USD","BK4581","LU0174119429.USD","LU2417539215.USD","LU0289739699.SGD","BK4585","LU2361044865.SGD","LU0882574139.USD","IE00B4JS1V06.HKD","VHT","LU1814569148.SGD","PJP","LU2211815571.USD","LU0820561909.HKD","LU2023250504.SGD","LU2468319806.SGD","LU2491050154.USD","BK4588","LU0471298777.SGD","LU0432979614.USD","LU2746668461.USD","LU0256863811.USD","LU0122379950.USD","LU0266013472.USD","SG9999018857.SGD","LLII","LU0109391861.USD","LU0006306889.USD","LU1868836914.USD","LU2491049909.HKD","LU2471134952.CNY","LU0353189763.USD","LU1551013425.SGD","LU2271345857.HKD","LU1868837136.USD","SG9999015952.SGD","LU0354030511.USD","LU1868837300.USD","SGXZ51526630.SGD","LU0882574055.USD","ATAI","LU2461242641.AUD","LU2168563687.JPY","BK4534","LU2361045086.USD","LU0198837287.USD","LU2462591350.SGD","LU1061106388.HKD","LU1989771016.USD","SG9999014880.SGD","SG9999018865.SGD","IE00BK4W5M84.HKD","LU1023059063.AUD","LU1917777945.USD","LU2471134523.USD","IE00B775H168.HKD","LU1291159041.SGD","LU2264538146.SGD","LU0353189680.USD","LU0158827948.USD","LU1280957306.USD","LU2237443549.SGD","LU0094547139.USD","MHIP","LU0708995401.HKD","LLYZ","IE0004445239.USD","LU0323591593.USD","LU0672654240.SGD","LU1145028129.USD","THNR","LU0225283273.USD","FTXH","IE0002141913.USD","LU2750360641.GBP","LU1069344957.HKD","LU2756315664.SGD","LU1868836591.USD","CURE","BK4007","LU0320765992.SGD","LU0133085943.USD","LU0234572021.USD","LU0256863902.USD","LU0471298694.HKD","LU2112291526.USD","SG9999015986.USD","WDNA","LU0417517546.SGD","IHE","GB00BDT5M118.USD","LU2106854487.HKD","ELIS","IYH","LU0097036916.USD","SG9999001176.SGD","LU0820562030.AUD","LU0640476718.USD","LU2462157665.USD","LU2360106947.USD","LU1267930730.SGD","LU0058720904.USD","LU2361044949.HKD","LU1983299246.USD","LU2089283258.USD","MEDI","HRTS","LU2028103732.USD","IE0009355771.USD","LU2896262040.SGD","LU2089984988.USD","LU2237443465.HKD","LU0823434740.USD","LU2168564495.EUR","SGXZ57979304.SGD","IE00BJJMRX11.SGD","IE00BWXC8680.SGD","LU1232071149.USD","IE00BFSS7M15.SGD","LU0964807845.USD","IE00B1XK9C88.USD","LU1979441026.SGD","LU0823416689.USD","IE00BJT1NW94.SGD","LU2552382132.HKD","LU0238689110.USD","SG9999014914.USD","AGNG","SG9999015945.SGD","TRUH","LU2602419157.SGD","LU0683600562.USD","LU0345770993.USD","LU2237438978.USD","IE00B4R5TH58.HKD","LU0320765059.SGD","LU2168564149.EUR","SGXZ81514606.USD","LU2023250330.USD","SG9999015978.USD","LLY","LU0079474960.USD","LU1804176565.USD","LU2237443978.SGD","ELIL","LU1366192091.USD","LU1035775433.USD","IE00B2B36J28.USD","BK4599","LU1691799644.USD","LU2168564222.USD","LU1093756325.SGD","OZEM","LU1974910355.USD","LU2236285917.USD","IE00B7KXQ091.USD","IE00BN29S564.USD","LU1629891620.HKD","LU0456855351.SGD","LU1720051108.HKD","LU2456880835.USD","IE00BJLML261.HKD","LU0109394709.USD","IE0001KFT4U8.USD","LU2552382058.USD","LU0466842654.USD","LU1057294990.SGD","PPH","IE00BKDWB100.SGD","MEDX","LU2746668974.SGD","LU1988902786.USD","LLYX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666713377","title":"Keros Therapeutics Announces Share Repurchase Authorization Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2666713377","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666713377?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:38","pubTimestamp":1788899909,"startTime":"0","endTime":"0","summary":"Keros Therapeutics ( ($KROS) ) just unveiled an announcement. On September 8, 2026, Keros Therapeutics announced that its board had authorized a $5...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/keros-therapeutics-announces-share-repurchase-authorization-program?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/keros-therapeutics-announces-share-repurchase-authorization-program?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KROS","LENZ","BK4139","BK4539","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377200","title":"Sangamo Therapeutics Completes Key Technology Asset Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377200","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377200?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:32","pubTimestamp":1788899575,"startTime":"0","endTime":"0","summary":"Sangamo Therapeutics ( ($SGMOQ) ) has issued an announcement. On September 4, 2026, Sangamo Therapeutics completed the court-approved sale of subst...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/sangamo-therapeutics-completes-key-technology-asset-sale?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/sangamo-therapeutics-completes-key-technology-asset-sale?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LENZ","BK4539","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666784377","title":"Robinhood initiated with a Buy at StoneX","url":"https://stock-news.laohu8.com/highlight/detail?id=2666784377","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666784377?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:30","pubTimestamp":1788899409,"startTime":"0","endTime":"0","summary":"StoneX analyst Mark Palmer initiated coverage of Robinhood (HOOD) with a Buy rating and $170 price target Published first on TheFly – the ultimate ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/robinhood-initiated-with-a-buy-at-stonex-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/robinhood-initiated-with-a-buy-at-stonex-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BLCK","CRPT","BK4539","HOOI","LU0566484027.USD","LU0053671581.USD","LU1861559042.SGD","HOII","ROBN","HOOC","HOOY","HOYY","FINX","LU1559883803.SGD","HOOX","HOOD","LU1861558580.USD","IAI","LU1815336091.USD","BK4547","BK4127","HOOG","HOOZ","HODU","SNEX","LU0757428866.USD","HOOW","BPAY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377793","title":"Kanzhun Details September 2026 Option Exercises and Share Count Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377793","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377793?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:28","pubTimestamp":1788899314,"startTime":"0","endTime":"0","summary":"Kanzhun Ltd Sponsored ( ($BZ) ) has issued an announcement. Kanzhun Limited filed a Form 6-K with the U.S. Securities and Exchange Commission on Se...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/kanzhun-details-september-2026-option-exercises-and-share-count-changes?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/kanzhun-details-september-2026-option-exercises-and-share-count-changes?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2039709279.SGD","BK4563","LU2351347302.SGD","BK4509","LU2187417386.USD","LU0359202008.SGD","LU0359201612.USD","BK4503","LU1688375341.USD","BK4077","BK4551","BK4535","LU1023057109.AUD","IE00B29SXG58.USD","LU2929501877.USD","BK4526","BK4585","BK4588","BK4505","BK4539","BK4130","BZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377609","title":"Acurx Pharmaceuticals - Files for Resale of 1,500,000 Common Shares - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377609","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377609?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:28","pubTimestamp":1788899307,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nFWN4500VQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4539","BK4563","ACXP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666369377","title":"Riskified Director Shachar Erez Disposes of USD 336,010 Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2666369377","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666369377?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:13","pubTimestamp":1788898419,"startTime":"0","endTime":"0","summary":"Riskified director Shachar Erez disposes of USD 336,010 common sharesRiskified director Shachar Erez reported selling 50,000 Class A Ordinary Shares on Sept. 3, 2026.Sale priced at USD 6.72 per share.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL9v9FBT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Riskified Director Shachar Erez Disposes of USD 336,010 Common Shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","BK4539","RSKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666337204","title":"Xponential Fitness Appoints Jennifer Ryu as CFO Effective Oct. 19, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2666337204","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666337204?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:06","pubTimestamp":1788897978,"startTime":"0","endTime":"0","summary":"Xponential Fitness appoints Jennifer Ryu as CFO effective Oct. 19, 2026Xponential Fitness named Jennifer Ryu chief financial officer, effective Oct. 19, 2026.Ryu previously served as executive vice pr","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDLhGvvG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4216","LU1878469433.USD","XPOF","BK4539","RGP","BK4123"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377658","title":"Keros Therapeutics announces $5M share repurchase program after Takeda payment","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377658","media":"TIPRANKS","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377658?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:05","pubTimestamp":1788897915,"startTime":"0","endTime":"0","summary":"Keros Therapeutics (KROS) announced that its board of directors has approved a $5M share repurchase program of the company’s common stock following...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/keros-therapeutics-announces-5m-share-repurchase-program-after-takeda-payment-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/keros-therapeutics-announces-5m-share-repurchase-program-after-takeda-payment-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","KROS","BK4139","LENZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666377570","title":"Oklo initiated with an Overweight at Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2666377570","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666377570?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:05","pubTimestamp":1788897907,"startTime":"0","endTime":"0","summary":"Piper Sandler initiated coverage of Oklo (OKLO) with an Overweight rating and $55 price target Published first on TheFly – the ultimate source for ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/oklo-initiated-with-an-overweight-at-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/oklo-initiated-with-an-overweight-at-piper-sandler-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4606","URAN","URA","OKLC","NLR","OKLO","OKLL","BK4081","OKLS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666372740","title":"Xponential Fitness, - Appoints Jennifer Ryu as CFO Effective October 19, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2666372740","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666372740?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:05","pubTimestamp":1788897901,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA1YN0Y5:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["XPOF","BK4216","BK4539","LU1878469433.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666372726","title":"Xponential Fitness, - Robert Julian to Step Down as Interim CFO, Remain as Consultant","url":"https://stock-news.laohu8.com/highlight/detail?id=2666372726","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666372726?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:05","pubTimestamp":1788897901,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA1YN0Y5:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1878469433.USD","BK4216","XPOF","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666037271","title":"Xponential Fitness, Inc. Appoints Jennifer Ryu as Chief Financial Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2666037271","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666037271?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:05","pubTimestamp":1788897901,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nTUA1YN0Y5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4539","LU1878469433.USD","BK4216","XPOF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666937739","title":"Protara Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2666937739","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666937739?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:05","pubTimestamp":1788897900,"startTime":"0","endTime":"0","summary":"NEW YORK, Sept.  08, 2026 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc.(Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, toda","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/08/3358109/0/en/protara-therapeutics-to-present-at-the-h-c-wainwright-28th-annual-global-investment-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4007","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666396377","title":"CAMP4 Therapeutics to Host Virtual Analyst Day to Discuss CMP-002 for the Treatment of SYNGAP1-Related Disorder on September 28, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2666396377","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666396377?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:05","pubTimestamp":1788897900,"startTime":"0","endTime":"0","summary":"WATERTOWN, Mass., Sept.  08, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-target","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/08/3358105/0/en/camp4-therapeutics-to-host-virtual-analyst-day-to-discuss-cmp-002-for-the-treatment-of-syngap1-related-disorder-on-september-28-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASO","BK4539","BK4139","CMP","LENZ","BK4561","BK4168","BK4200","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666372093","title":"Press Release: Korsana Biosciences Completes Closing of Merger with Cyclerion Therapeutics and Previously Announced Private Placement of $380 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2666372093","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666372093?lang=en_us&edition=fundamental","pubTime":"2026-09-09 04:05","pubTimestamp":1788897900,"startTime":"0","endTime":"0","summary":"Advancing lead program KRSA-028 toward the clinic, with Phase 1 healthy volunteer data expected mid-2027 and interim proof-of-concept data in Alzheimer's patients anticipated by year-end 2027 or first","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03160","BK4585","BK4139","TM","BK4588","BK4539","BK4099","LENZ","BK4007","BK4604","BK4555"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666372117","title":"ME Therapeutics Advances Dual-Target CAR and STING mRNA Programs as NASDAQ Plans Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2666372117","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666372117?lang=en_us&edition=fundamental","pubTime":"2026-09-09 03:32","pubTimestamp":1788895960,"startTime":"0","endTime":"0","summary":"An announcement from ME Therapeutics Holdings, Inc. ( ($TSE:METX) ) is now available. ME Therapeutics reported progress in its in vivo CD19/CD22-ta...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/me-therapeutics-advances-dual-target-car-and-sting-mrna-programs-as-nasdaq-plans-progress?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/me-therapeutics-advances-dual-target-car-and-sting-mrna-programs-as-nasdaq-plans-progress?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["QQQA","QID",".IXIC","PSQ","QQQ","LENZ","QDTE","BK4139","QQQJ","TQQQ","JEPQ","GPIQ","BK4097","03086","NVIW.SI","QLD","ONEQ","QQQM","SQQQ","QQQY","NDX","TQQY","LU2065732104.USD","BK4539","BK4007","QQQE","PRGS","QYLG","FTEC","IYW","NQmain","MNQmain","TECS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666372629","title":"Shares of Beam Therapeutics Retreat After Updated Trial Data Disappoints","url":"https://stock-news.laohu8.com/highlight/detail?id=2666372629","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666372629?lang=en_us&edition=fundamental","pubTime":"2026-09-09 03:24","pubTimestamp":1788895440,"startTime":"0","endTime":"0","summary":"Beam Therapeutics shares were down after the company shared updated data for its trial of a treatment for the genetic condition alpha-1 antitrypsin deficiency.Shares declined 9% to $26.88 on Tuesday. The stock is roughly flat this year.In a Phase 1/2 trial evaluating BEAM-302 for AATD, the treatment was well tolerated with an acceptable safety profile, the company said.The updated results were not worse than previous data, but were not numerically better, either, Evercore ISI analysts led by Cory Kasimov said.At the 12-month mark, total alpha-1 antitrypsin in treated patients came down to 13.5 uM  to 14.4 uM, compared with 16.1 uM at the nine-month mark. The treatment is supposed to increase alpha-1 antitrypsin, a protein made by the liver.About 41% of patients experienced adverse events, with the most common being mild-to-moderate infusion-related reactions.Based on the feedback from the Food and Drug Administration, Beam plans to pursue an accelerated approval pathway for the treatme","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4505","BK4535","BK4588","LU1861559042.SGD","BK4611","LU1861558580.USD","BK4007","BEAM","BK4539","BK4139","BK4556","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666517372","title":"Waterdrop Shares Rise After Q2 Results, New Buyback Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2666517372","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666517372?lang=en_us&edition=fundamental","pubTime":"2026-09-09 03:08","pubTimestamp":1788894515,"startTime":"0","endTime":"0","summary":"Waterdrop  shares were up over 5% in Tuesday trading following its Q2 results and a new share repurchase program.Earlier, the company reported a Q2 net profit attributable to its ordinary shareholders of 125.8 million Chinese renminbi , down from 140.2 million renminbi a year ago.Revenue for the three months ended June 30 was 1.45 billion renminbi, up from 838 million renminbi a year earlier.The company said its board has approved a new program to repurchase up to $50 million of its American Depository shares through Sept. 10, 2027.The firm also declared a dividend of $0.03 per ADS, payable Nov. 6 to stockholders of record Oct. 9.Price: 1.08, Change: +0.06, Percent Change: +5.88","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CWEB","02843","YXI","CHAU","KGRN","02823","XPP","82822","WDH","KCAI","YANG","BK4539","ASHR","FXP","02822","BK4509","82823","KWEB","FLCH","ASHS","BK4173","82843","YINN"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":45,"pageCount":15,"totalSize":897,"code":"91000000","status":"200"}]}}